We are pleased to announce that, starting in January 2025, we will launch our new service dedicated to evaluating cosmetic products’ sun protection using the HDRS (Hybrid Diffuse Reflectance Spectroscopy) method, in accordance with ISO/DIS 23698.
HDRS is a new method that enables clinical tests to be carried out to assess SPF, UVAPF and Critical WaveLength (CWL) while eliminating erythematous and/or pigmented skin reactions, representing a major ethical advance in sun protection testing.
This innovative method solution guarantees precise and reproducible results and allows you to validate the UV performance of your sunscreen products with great efficiency.
Guillaume Lejeune Sales Development Representative
commercial@weneos.com
176 Rue Robert Schuman
60610 Lacroix-Saint-Ouen
France
Welcome to this 33rd edition of ZOOM, a magazine dedicated to preclinical trials and clinical…
Precision and reliability are essential in dermatology and aesthetics. The Antera 3D CS by Miravex…
PhD Trials, one of the leading CROs for performing in vivo studies with cosmetic products…